4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-15-003490
CIK 0001369786operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 3:58 PM ET
Size
6.7 KB
Accession
0001181431-15-003490
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Award
Common Stock
2015-02-25+3,683→ 27,902 total - Award
Stock Option to Buy
2015-02-25+6,840→ 6,840 totalExercise: $27.15Exp: 2025-02-25→ Common Stock (6,840 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 25, 2016.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 3:58 PM ET
- Size
- 6.7 KB